1. Home
  2. Courses
  3. The Ws and Hs of Empagliflozin in Clinical Practice
Skip to main content
eLearning on BoehringerOne

The Ws and Hs of Empagliflozin in Clinical Practice

Presenters

Subodh Verma, MD, PhD, FRSC, FAHA
Course speaker
Subodh Verma, MD, PhD, FRSC, FAHA
  • 23 Mins 20 Secs

  • Self paced

    Upon completion you will earn a certificate.

Description:

This e-learning course is tailored for healthcare professionals seeking comprehensive insights into the utilization of empagliflozin in the management of heart failure. This is designed to address the frequently asked questions on initiation, maintenance and concomitant use with other medications.

Estimated time of Completion: 23 mins. and 20 secs.

CPD Points: 1 Point

Program No: PROG-2024-75383

 

Course Outline

  • FAQ 1: Who can benefit from Empagliflozin as a Cardiac Drug?
  • FAQ 2: What is Empagliflozin’s mechanism of action in providing cardiovascular efficacy and Safety in Heart Failure Patients?
  • FAQ 3: When can we give Empagliflozin in acute or chronic Setting of Heart Failure?
  • FAQ 4: How do you sequence the numerous Heart Failure Medications?
  • FAQ 5: How do you manage and monitor the acute eGFR dip observed with Sodium glucose co-transporter 2 inhibitors?